[Answered] NR351-63520 Week 5 Discussion: Evidence to Support Nursing Practices

Purpose

The purpose of this discussion is for learners to demonstrate their ability to search for evidence in the scholarly nursing literature and share with colleagues.

Course Outcome

This discussion enables the student to meet the following course outcome:

  • CO 5: Discuss theories and evidence-based practice in the planning of patient-centered care. (POs 1, 8)

Due Date

  • Answer post due by Wednesday 11:59 p.m. MT in Week 5
  • Two replies to classmates and/or instructor due by Sunday 11:59 p.m. MT at the end of Week 5

Points Possible

50 points

Directions

  • Discussions are designed to promote dialogue between faculty and students, and students and their peers. In discussions students:
    • Demonstrate understanding of concepts for the week
    • Integrate scholarly resources
    • Engage in meaningful dialogue with classmates
    • Express opinions clearly and logically, in a professional manner
    • Use the rubric on this page as you compose your answers.
Discussion

Evidence is necessary to improve our nursing practice. Using the CINAHL database in the Chamberlain Library, search for and locate a scholarly professional nursing journal article that meets these criteria:

  • Full-text
  • English language
  • Peer-reviewed
  • NOT an Evidence-Based Care Sheet or CINAHL Guide
  • Published in the past five years
  • Contains evidence to support a nursing practice in your practice area

Summarize this article in one paragraph. Explain why you selected this article. Provide an APA reference for this article.

Reply to a peer who has selected a different article. Provide feedback on that peer’s article choice and APA reference format. Your peers will also provide feedback on your article choice and APA reference format.

 

 

 

Solution

Week 5 Discussion: Evidence to Support Nursing Practices

In this post, the primary discussion point is about the pediatric cardiac population and also the usage of household milrinone for symptom control. Milrinone is categorized as a type III phosphodiesterase inhibitor. It helps you to boost cardiac output and cardiac contractility of individuals with a weak left sided heart. It’s usually administered intravenously and also by way of a central line like a PICC line. Nurses are essential in order to administer this particular…………………please follow the link below to purchase the solution at $5